Logo image
Evaluation of chondrocyte death in canine osteochondral explants exposed to a 0.5% solution of bupivacaine
Journal article   Open access   Peer reviewed

Evaluation of chondrocyte death in canine osteochondral explants exposed to a 0.5% solution of bupivacaine

G.S. Hennig, G.L. Hosgood, L.J. Bubenik-Angapen, S.K. Lauer and T.W. Morgan
American Journal of Veterinary Research, Vol.71(8), pp.875-883
2010
pdf
Published852.83 kBDownloadView
Published (Version of Record)CC BY-NC V4.0 Open Access

Abstract

Objective To evaluate chondrocyte death in canine articular cartilage exposed in vitro to bupivacaine with and without methylparaben and to compare viability for cartilage with intact or mechanically debrided surfaces. Sample Population Both glenohumeral joints from 10 adult canine cadavers. Procedures 10 osteochondral cores were harvested from each of the 20 humeral heads; synovium and 1 core from each joint were examined to verify joint health, and the other 9 cores were exposed to canine chondrocyte culture medium (CCCM), a 0.5% solution of bupivacaine, or 0.5% solution of bupivacaine with methylparaben for 5, 15, or 30 minutes. Results For the superficial zone of surface-intact chondrocytes, bupivacaine with methylparaben caused a significantly higher percentage of chondrocyte death at 5 minutes (47.7%) than did bupivacaine (23.6%) or CCCM (25.4%). Bupivacaine (53.8%) and bupivacaine with methylparaben (62.5%) caused a significantly higher percentage of chondrocyte death at 30 minutes than did CCCM (20.0%). For the superficial zone of chondrocytes with debrided surfaces, bupivacaine with methylparaben caused a significantly higher percentage of chondrocyte death at 30 minutes (59%) than it did at 5 minutes (37.7%). Bupivacaine with methylparaben caused a significantly higher percentage of chondrocyte death at 30 minutes (59.0%) than did CCCM (28.9%). For middle and deep zones of chondrocytes, treatment solution and surface debridement had minimal effects on percentage of chondrocyte death. Conclusions and Clinical Relevance Bupivacaine and bupivacaine with methylparaben were cytotoxic to canine articular chondrocytes in vitro. Intra-articular administration of bupivacaine is not recommended for clinical use until additional studies are conducted.

Details

Metrics

27 File views/ downloads
75 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.43 Anesthesiology
1.43.202 Regional Anesthesia
Web Of Science research areas
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image